The Crazy Economics of the Wind Industry in Two Charts
Making sense out of the massive influx of wind power—or occasional lack thereof.
—Timothy Maher, managing editor
The Guitarist with 78 Fingers
Ben Johnson talks with musicians about technology – how it’s changed the way they write, perform, and even think about what music actually is.
—David Sweeney, marketing communications manager
What Is Alibaba and Why Is It About to Become the Biggest IPO in Years?
A good rundown of the basic facts surrounding the U.S. IPO of the Chinese e-commerce giant.
—Mike Orcutt, research editor
Never Say Die
Fascinating research from reptuable scientists’ efforts to find ways to forestall aging and death.
—Kyanna Sutton, senior Web producer
Newsweek’s deep dive into how venture capital plays out in the gender dynamics of entrepreneurship.
40 Maps That Explain the Middle East
A brief history of the Middle East encapsulated in great infographic maps.
Nadella’s Bid to Fix Microsoft: What Ballmer Didn’t Dare
Forbes profiles new Microsoft CEO Satya Nadella and explains his bet on cloud computing.
—Antonio Regalado, senior editor, business
Apple on Medical Tech Hiring Spree, a Possible Hint of iWatch Plans
Nice Reuters sleuthing on Apple’s plans for medical gizmos. Signal processing very hot.
Phineas Gage, Neuroscience’s Most Famous Patient
Ever since the mid-19th century, the case of a man who survived 12 years after an iron bar blasted through his skull has been a mirror for changing theories about the brain.
—Linda Lowenthal, copy chief
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.